Sponsored by

VGoodiez 420EDC
  • Welcome to VaporAsylum! Please take a moment to read our RULES and introduce yourself here.
  • Need help navigating the forum? Find out how to use our features here.
  • Did you know we have lots of smilies for you to use?

Law Atrocious and Horrible Cannabis News

"DEA hasn’t been entirely obstinate amid the paradigm shift in public opinion and policy. It’s routinely increased production quotas for marijuana and psychedelics for research purposes as interest within the scientific community expands. And it also ended a long-standing monopoly on cannabis cultivation for research by approving additional manufacturers."​
This ^^ ONLY because they got their ass sued. DEA has zero claim to virtue in this.

DEA Celebrates 50-Year Anniversary While Failing To Win The Drug War



The Drug Enforcement Administration (DEA) celebrated its 50th anniversary this week—marking a half century of enforcing criminalization laws that have failed to fulfill the mission to eradicate drugs at the same time that nearly half of the country has legalized marijuana and psychedelics reform is also booming.

Since its founding on July 1, 1973 through an executive order issued by President Richard Nixon, DEA’s budget has swelled and its workforce has expanded—but illicit drugs remain widely accessible across the U.S., with waves of new, even deadlier substances continually emerging under prohibition while others like cannabis have been increasingly legalized at the state level.

“Over the past 50 years, DEA has worked to keep American communities safe and healthy by preventing criminal drug networks and drug-related violence and deaths,” the agency, which replaced the former Bureau of Narcotics and Dangerous Drugs five decades ago, said in a press release about its anniversary.

Yet while the agency continues to make thousands of arrests every year, while destroying controlled substances and seizing assets along the way, the anniversary also serves as a reminder that the war on drugs has been one of the costliest and least successful campaigns to be waged by the federal government. Indeed, more than 100,000 Americans died from drug overdoses in 2021 alone—a record high.

And when it comes to drug trafficking, even major disruptions to international enterprises haven’t stymied the flow of the substances. The trends for each drug have simply fluctuated, as the U.S. Sentencing Commission (USSC) shows. From 2018 to 2022, the percent of heroin trafficking cases declined by 37.4 percent—but the percent of fentanyl cases skyrocketed 435.4 percent, for example.

Meanwhile, reform advocates have made massive strides in combating the drug warrior narrative and affecting change at the local and state levels, with 23 states now having legalized marijuana for adult use and two having ended prohibition on certain psychedelics.

Federal reform has lagged, comparatively, but DEA itself has now found itself in a position where it will have to reconcile the science on cannabis and reach a decision about whether to remove it from Schedule I of the Controlled Substances Act (CSA) under a directive issued by President Joe Biden last year.

DEA hasn’t been entirely obstinate amid the paradigm shift in public opinion and policy. It’s routinely increased production quotas for marijuana and psychedelics for research purposes as interest within the scientific community expands. And it also ended a long-standing monopoly on cannabis cultivation for research by approving additional manufacturers.

Meanwhile, the agency also lost legal control over hemp containing up to 0.3 percent THC following the passage of the 2018 Farm Bill, and it is now working to finalize rules on synthetic cannabinoids like delta-8 THC. DEA has also faced numerous lawsuits over everything from psilocybin scheduling to the way it processes Freedom of Information Act (FOIA) requests.

As Reason reported this week, DEA’s own museum is rife with subtle acknowledgements that the agency has failed to win the drug war. Last year, the museum even publicly recognized the fact that racially discriminatory drug laws are partly responsible for the agency’s own founding.

Many congressional lawmakers have sharply criticized the criminalization model for drugs—especially marijuana. Some Democrats have also introduced legislation to federally decriminalize all currently illici substances and shift to a public health-centered approach to addiction.

But in the interim, there’s no sign that Congress will do away with DEA anytime soon despite its critical—and increasingly widely acknowledged—shortcomings. The question is whether it will work to be a partner in science-based efforts to modernize federal drug policy or continue the 50-year-long game of prohibitionist Whac-A-Mole.
 
I wonder how much we pay these cretins for this blather....wow.


DEA Says Instead Of Doing Drugs You Should Spend More Time On Instagram And Playing Video Games For A ‘Natural High’


The Drug Enforcement Administration (DEA) has a message for young people: Instead of doing drugs, you should focus on becoming an Instagram influencer.
The federal agency is promoting tips on how to get a “natural high” as an alternative to drugs, sharing what it says are “7 Better Highs” such as becoming famous on Instagram, playing video games and going to a pet store to look at animals.

Some of the suggestions are fairly standard like hiking, playing sports and visiting an amusement park. But DEA—which is also known for its attempts to decode emojis that it claims are used to buy drugs—has a few recommendations that are off the beaten path.

“It’s fun to post pics on Instagram and also see what your friends are doing on the app. But if you took it a little bit more seriously, you could take over the world and become a young trendsetter,” the post on DEA’s teen-focused Just Think Twice site says.

“OK, so even if you can’t become rich and famous from the app, if you take really awesome pictures you can gain a decent following while showing off your skills,” it says.

The irony of DEA’s blog post is that most of the activities the agency lists as alternatives to getting high are exactly the same types of endeavors that many people use cannabis to enhance the experience of, including going to amusement parks, playing video games and creating music.

“Don’t let boredom be one of the reasons you try drugs,” the agency says, as it recommends video games—an activity that a 2021 survey found 54 percent of gamers perform while using cannabis.

“Do you want to take a little escape from reality altogether?” it asks, without a hint of irony. “Playing video games is an awesome way to do so.”

DEA also said that learning to sing could be a natural high.

“Be honest. Does your family cringe whenever you (try to) sing along with your favorite songs on the radio?” it asked. “You know what you can do? Learn how to sing by taking voice lessons on YouTube! After a while, you may surprise yourself, and others, by getting really good. Either way, the challenge is a fun way to occupy a lot of your time.”

“Who needs to do drugs? All of these activities can give you a natural high,” it concludes.

Meanwhile, DEA celebrated its 50th anniversary last week—marking a half century of enforcing criminalization laws that have failed to fulfill the mission to eradicate drugs at the same time that nearly half of the country has legalized marijuana and psychedelics reform is also booming.

DEA is also being actively tasked with looking at the science of cannabis and reaching a decision about whether to remove it from Schedule I of the Controlled Substances Act (CSA) under a directive issued by President Joe Biden last year.

Last year, DEA’s own museum publicly recognized the fact that racially discriminatory drug laws are partly responsible for the agency’s own founding.
 
eh, not really "legalization" per se but thought it was somewhat related when a major USA corp enters the cannabis market.....as for $650 for a fucking metered vape device company...wow. Ok, its a dry herb vape....so what. Got to sell a LOT of dang vapes to make that up. I don't see it, really. But maybe that's why I'm not rich.


Philip Morris acquiring Cannabis inhaler developer for up to $650 million

The Israeli company’s main product is a metered-dose inhaler for pain reduction treatment using medical cannabis.​


Philip Morris, the international tobacco giant, is acquiring the Israeli company Syqe Medical in a deal that could reach $650 million, Calcalist has learned. Syqe’s main product is a metered-dose inhaler for pain reduction treatment using medical cannabis.


The deal consists of several milestones. Philip Morris will initially invest $120 million to support the process of obtaining FDA approval for Syqe's inhaler. If the approval is received after passing clinical trials, Philip Morris will proceed to purchase all the shares of the Israeli company for $650 million.


The transaction will be conducted through Philip Morris' subsidiary Vectura, which specializes in the field of inhalers. Philip Morris previously acquired the British company for one billion pounds in 2021 as part of its strategy to transition to smoke-free smoking.


Philip Morris previously invested $20 million in Syqe back in 2016.


The acquisition of Syqe marks one of the largest transactions in Israel's medical technologies field over recent years. If the $650 million valuation is achieved, Syqe will become one of the ten largest cannabis companies globally, joining the ranks of Tilray and Aurora.


This exit is highly significant for all of Syqe's investors, considering that the total investments in the company to date amount to only $80 million. The company's founder and CEO, Perry Davidson, holds a relatively large share of over 10% of the company, with other investors including OurCrowd, former Retalix founders Barry Shaked and Brian Cooper, GlenRock, Leon Recanati’s investment firm, Shavit Capital, and Bank Discount.



Established in 2011 by Davidson, who still serves as the CEO, Syqe holds around 120 patents resulting from more than eight years of development. The main innovation in Syqe's inhaler is the use of raw inflorescence of the cannabis plant, not its processed products, and the ability to measure an exact dose intended for the patient.


Presently, over 80% of medical cannabis consumers use smoking and vaping products, leading to potential overdoses. Syqe's inhaler provides relief without causing the psychoactive effects from excessive dosing.



As of now, Syqe's inhaler is available in Israel and Australia, which are relatively small markets. The Israeli market, for example, is estimated at only 100 million shekels (approximately $27.5 million) per year, serving approximately 50,000 medical cannabis patients.


In the past, the inhalers were marketed and distributed through the Israeli pharmaceutical company Teva, but recently, Syqe opted for independent marketing and signed cooperation agreements with the Ministry of Defense and the Meuhedet HMO.


Syqe's primary target market is outside of Israel, with its FDA approval process in the United States being a critical milestone. Philip Morris' expertise through Vectura will be instrumental in obtaining this approval. If successful, Syqe will be the first company worldwide to secure FDA approval for using raw cannabis inflorescence as medicine.



Philip Morris, known for its Marlboro brand, is one of the largest cigarette manufacturers globally, valued at $154 billion on Wall Street. It aims to reinvent itself amid the decreasing popularity of traditional cigarettes, with over a third of its revenue now coming from smokeless products, including the iQOS electronic cigarette.


A few years ago, Philip Morris initiated a "beyond nicotine" strategy, expanding its product range into botanicals like chamomile and fennel, as well as sleep and relaxation aids. The cannabis market is still seen as a potential growth engine for tobacco companies despite recent market shifts.



According to Philip Morris, the medical cannabis market is worth $24 billion with an annual growth rate of 15% until 2030. The wellness market, which includes cannabis-based sedatives and sleep aids, is estimated at an additional $4 billion with a growth rate of 8%. Syqe declined to comment.
 
Fuck Massacard!

1690487953688.png




Mastercard blocks marijuana transactions

Mastercard has told financial institutions to stop allowing marijuana transactions on its debit cards, dealing a blow to an industry already on the fringes of the financial system in the United States.


Most banks in the country do not service cannabis companies as marijuana remains illegal at the federal level despite several states legalizing its medicinal and recreational use.


“As we were made aware of this matter, we quickly investigated it. In accordance with our policies, we instructed the financial institutions that offer payment services to cannabis merchants and connects them to Mastercard to terminate the activity,” a spokesperson for the company said on Wednesday.


Marijuana remains illegal at a federal law level so most banks do not service cannabis companies.


“The federal government considers cannabis sales illegal, so these purchases are not allowed on our systems,” the spokesperson added.


The move, which would rob cannabis buyers of another easy-to-use mode of payment, was first reported by Bloomberg News.
 
Fuck Massacard!

This was my reply to this news elsewhere:

"As horrible as it sounds, maybe it's shit like this that needs to happen to scare the fuck outta the feds and finally cave to the inevitable...?

I pay cash for product anyway, cuz of this ridiculous state... come to think of it, I always have. While it no doubt sux for others, it ain't gonna affect me too much, personally..."

I honestly don't know, but it felt right thinking it... thoughts anyone else? Is there any "logic" there, or am not half, but fully BAKED...CRISPIFIED?
 
I honestly don't know, but it felt right thinking it... thoughts anyone else? Is there any "logic" there, or am not half, but fully BAKED...CRISPIFIED?
I doubt the feds will care if Mastercard allows it or not. They're already blocking the banks from doing business with cannabis companies because they can. They're federally insured.. It's a cash business here in Michigan.
 
I doubt the feds will care if Mastercard allows it or not. They're already blocking the banks from doing business with cannabis companies because they can. They're federally insured.. It's a cash business here in Michigan.

But say all cc companies do this, wouldn't you think it'd stifle business somewhat, especially going forward, as the market explodes..?
 
But say all cc companies do this, wouldn't you think it'd stifle business somewhat, especially going forward, as the market explodes..?
I've always thought it was idiotic that the dispos don't take credit cards. Why the feds and the cc companies aren't on board is beyond me.

My caregiver, when setting up his large grow, had his credit card cancelled because of buying grow equipment ffs.... Now this was early on but still...
 
1692900798680.png



More Than A Year After Being Confronted With Errors In FBI Marijuana Data, DOJ Punts Investigation To FBI Itself




A Justice Department watchdog took more than a year to reply to an attorney’s letter outlining concerns about apparent defects in how the Federal Bureau of Investigation (FBI) collects and reports data on marijuana possession arrests—then finally responded by suggesting that the FBI should investigate itself.
Eric Sterling, a longtime drug policy reform activist and former congressional staffer, sent a letter to DOJ’s Office of the Inspector General (OIG) in May 2022, claiming to have discovered that a Maryland police department was reporting cannabis possession citations issued under the state’s decriminalization law at the time as arrests as part of a long-standing data sharing partnership with FBI. If other state and local law enforcement agencies were similarly lumping those penalties together, Sterling reasoned, the practice could significantly alter FBI’s annual reports, which are used to inform public reporting and policymaking.

Including simple citations for marijuana possession in the same category as arrests—where people are taken into custody, booked and processed—would inflate the number of recorded arrests, potentially skewing public perceptions of how police prioritize resources and painting an inaccurate picture of how policies such as decriminalization and legalization are being implemented by law enforcement.

Sterling, who serves as an appointed member of Policing Advisory Commission for Montgomery County, Maryland, recommended in his letter that the DOJ inspector general’s office launch a formal investigation.

Last week—about 14 months after Sterling sent the inquiry—the office finally replied. Rather than address the apparent problem, however, the OIG investigations division said it had “determined that the matters that you raised are more appropriate for review by another office within the DOJ” and referred the inquiry to FBI’s own inspection division.

The delay, Sterling told Marijuana Moment in a phone interview on Monday, suggests DOJ’s own investigators are “overwhelmed and not able to process the incoming complaints in any kind of timely manner, and the ability to respond to much more serious instances of misconduct is compromised.”

But timeliness could be crucial, as letting the matter languish for more than a year could mean yet another annual Uniform Crime Report from FBI that fails to accurately reflect cannabis policy changes being enacted across the country.

A spokesperson for DOJ’s Office of the Inspector General declined to comment, referring Marijuana Moment “to the FBI for any further questions on this topic.” FBI, however, did not immediately respond to a request for comment.

The issue is especially relevant in jurisdictions that decriminalize marijuana, as those policies typically maintain some level of civil penalty for possession—the kind of citation that might be misreported as an arrest.

“We’ve got very senior members of Congress introducing major proposed federal reforms of the marijuana laws. You have state after state seriously considering whether to abandon marijuana prohibition. And in so many of these states, a primary issue is, how much does marijuana prohibition and its enforcement cost?” Sterling, who founded the Criminal Justice Policy Foundation and has served on numerous other drug policy reform organizations’ boards, said. “A primary driver of those costs are arrests.”

He said that by failing to require a disaggregation of cannabis citation versus arrest data, FBI is “handicapping” the debate over marijuana policy reform “by generating data that leads to distorted pictures of what the police are doing.”

For instance, proponents of marijuana decriminalization and legalization often argue that the policy change would free up law enforcement resources, which could then be spent on other priorities. Miscategorizing citations as arrests would effectively understate that impact and could even exaggerate crime levels.

FBI’s cannabis enforcement reporting is also compromised by the fact that local and state police are not required to share data to inform the agency’s annual report, meaning it offers an incomplete overview of national law enforcement activities. The agency itself says that certain data may not be comparable to previous years because of different levels of participation over time. The latest quarterly report released in June included data from “12,518 of 18,900 law enforcement agencies in the country.”
 
I'm absolutely sick to death of hearing politicians (of all stripes) tell us what THEY want instead of listening to what the ELECTORATE wants and in the case of cannabis the polls are very, very clear.

Suck it up, DeSantis. We don't give a fuck about your unsupported cannabis bias and look forward to your FL electorate shoving it up your ass and approving the full rec legalization referendum that will be on the ballot.

DeSantis claims Legalization ‘Hasn’t Worked’


Ron DeSantis Affirms Strong Anti-Cannabis Stance, Dismissing Federal Legalization and Expressing Concerns Over Cannabis Industry Impact.


Republican presidential hopeful Ron DeSantis has doubled down on his anti-cannabis position, stating once again that he had no plans for federal legislation and that ‘drugs are killing this country’.


The Florida Governor was questioned during a recent campaign stop in Iowa on his stance on cannabis legalisation both in his state, which is currently considering whether a legalisation vote will appear on the 2024 ballot, and federally.


Asked whether he would ‘go along with the cannabis industry’ and legalise at a federal level if elected, Mr DeSantis stuck to his hardline stance, making a number of unsubstantiated claims about the impact of legalisation on other states.


Responding to an attendee who said they knew people who have been impacted by cannabis induced psychosis, Mr DeSantis said that the growing potency of cannabis was a ‘real, real problem’.


“I think when kids get on that, I think it causes a lot of problems and then, of course, you know, they can throw fentanyl in any of this stuff now.”


He went on to target San Francisco and its more liberal stance of drug policy, stating that when he visits the city ‘within five minutes I see somebody defecating on the sidewalk in broad daylight’.


Focusing on his own state, Mr DeSantis said he would ‘abide by’ the vote to legalise medical cannabis, but would not ‘take action now to make it even more available’.


Referencing Colorado, the first US state to legalise cannabis for adult-use, he claimed that ‘the black market for marijuana is bigger and more lucrative than it was before legalisation’.


This claim goes against both private and government data suggesting the size of the illicit market has been drastically reduced since legalisation in 2014.
 
This guy is a moron...oh, and a liar. Love this one: “I proudly consider the tribe my friends, and I respect their tribal sovereignty,” the congressman wrote.

The fuck he does....

And he's hooked up with Sabet for whom being a drug warrior is like being a Crusader for God. Its religion with him. Now, I never wish anyone ill health as karma truly is a bitch. But I hope to live long enough to see Sabet...another inveterate liar...shuffle off this mortal coil...and I won't shed a tear.

Come to think of it...I sort of view all politicians as lying morons....or at least they lie and think we are morons enough to believe them. Which, sadly, is true of a lot of people with no critical thinking skills.

Cheers

GOP Congressman’s Bill Would Cut Federal Funding For States And Tribes That Legalize Marijuana


Legislation introduced on Friday by a North Carolina congressman seeks to slash a portion of federal funding to individual U.S. states as well as Native tribes that legalize marijuana.

The so-called Stop Pot Act, sponsored by U.S. Rep. Chuck Edwards (R-NC), would withhold 10 percent of federal highway funding to jurisdictions “in which the purchase or public possession of marijuana for recreational purposes is lawful.” Introduction of the bill comes less than a week before a tribe in Edwards’s home state votes on an adult-use marijuana legalization referendum.

Edwards argues that state and tribal laws allowing cannabis use by adults are an affront to U.S. law.

“The laws of any government should not infringe on the overall laws of our nation, and federal funds should not be awarded to jurisdictions that willfully ignore federal law,” he said in a press release. “During a time when our communities are seeing unprecedented crime, drug addiction, and mental illness, the Stop Pot Act will help prevent even greater access to drugs and ease the strain placed on our local law enforcement and mental health professionals who are already stretched thin.”


Edwards previewed the bill in an op-ed published last month in Cherokee One Feather, where he warned a tribe in his state, the Eastern Band of Cherokee Indians (EBCI), against adult-use legalization. EBCI members are set to vote Thursday on a referendum that would legalize marijuana for all adults 21 and older, regardless of tribal membership.

“I proudly consider the tribe my friends, and I respect their tribal sovereignty,” the congressman wrote. But to allow North Carolinians to buy cannabis on tribal land, he said, “would be irresponsible, and I intend to stop it.”

EBCI Principal Chief Richard Sneed has since described Edwards’s comments as “a major political blunder.”

Writing in Cherokee One Feather, Sneed said he believes Edwards “overstepped his authority,” noting that the congressman is “a non-Indian, elected official telling a sovereign tribal nation how they ought to handle their business.”

If it becomes law, however, Edwards’s bill, which is cosponsored by Rep. Gregory Murphy (R-NC), would target more than just Indigenous people in his home state. It would also mean a financial hit to states in which nearly half of all Americans live, not to mention tribes in other states that have already launched marijuana-related ventures.

Two organizations have endorsed the bill so far, according to Edwards’s press release: the prohibitionist group Smart Approaches to Marijuana (SAM) and the Christian Action League.

Kevin Sabet, SAM’s president and CEO, said in a statement released by Edwards’ office that “today’s marijuana isn’t Woodstock Weed,” referring to an outdoor music festival held 54 years ago. “It is a highly engineered drug that’s often wrapped in kid-friendly packaging, with potencies of up to 88 percent. The legalization movement has worsened America’s mental health and addiction crisis by preying on communities of color and young people.”

To be clear, no U.S. state where cannabis is legal allows products to be marketed to children. And despite some evidence that a small portion of people might experience psychosis associated with marijuana use, other recent research has indicated that psychosis symptoms may actually improve among people who use marijuana.
 
Here is a little walk down memory lane...and a clear picture of how the fucking anti-drug warriors worked....including the life long anti-drug warrior who occupies an office in a famous house in DC. Yeah, him...he was an architect and/or supporter of anti-drug...and anti-MJ...laws/rules for a VERY long time including mandatory minimum sentencing and the abuses of justice that resulted from that fascist shit. So, I have never expected much from that quarter.

Read it and weep.


35 Years Ago: DEA Judge's Landmark Ruling on Cannabis Reclassification

35 Years Ago Today: DEA’s Chief Administrative Law Judge Ruled That Cannabis Should Be Reclassified Under Federal Law.​


Today marks the 35-year anniversary of an administrative ruling by the US Drug Enforcement Administration’s (DEA) Chief Administrative Law Judge determining that cannabis possesses accepted medical utility in the United States and, therefore, it ought to be available to qualified patients.

The ruling, issued on September 6, 1988 by DEA Judge Francis Young In the Matter of Marijuana Rescheduling determined: “Marijuana, in its natural form, is one of the safest therapeutically active substances known to man. By any measure of rational analysis marijuana can be safely used within a supervised routine of medical care.”

Young continued: “It would be unreasonable, arbitrary and capricious for DEA to continue to stand between those sufferers and the benefits of this substance in light of the evidence in this record.”

Judge Young’s ruling was in response to an administrative petition filed in 1972 by NORML challenging marijuana’s Schedule I classification under federal law. Federal authorities initially refused to accept the petition until mandated to do so by the US Court of Appeals in 1974, and then refused to properly process it until again ordered by the Court in 1982. In 1986, 14-years after NORML filed its initial petition, the DEA finally held public hearings on the issue before Judge Young, who rendered his decision two years later.

However, then-DEA Administrator John Lawn ultimately rejected Judge Young’s determination, and in 1994, the Court of Appeals allowed Lawn’s reversal to stand – maintaining marijuana’s classification as a Schedule I prohibited substance with “no accepted medical use,” and a “lack of accepted safety … under medical supervision.”

Since that time, the agency has similarly denied three additional petitions. The most recent denial came in 2016.

Commenting on the 35-year anniversary of Judge Francis Young’s decision, NORML’s Deputy Paul Armentano said: “This anniversary is hardly an occasion for celebration. Rather, this milestone reflects the reality that advocates have been engaged in a multi-decade long struggle to compel the federal government to acknowledge the obvious: that cannabis possesses legitimate therapeutic benefits. It also highlights the fact that the federal government’s ongoing refusal to do so has been strictly a political decision. Let’s be clear. Judge Young didn’t call for ‘more research.’ Judge Young didn’t say the evidence was equivocal. Judge Young was convinced that the science and evidence available at that time made the case for cannabis to be legally available to patients nationwide. The evidence in support of this position has only grown exponentially stronger, and quite frankly undeniable, over the past three and one-half decades.”

Last week, Bloomberg News obtained a letter from a top Department of Health and Human Services official recommending that the Drug Enforcement Administration reclassify cannabis to a Schedule III controlled substance under federal law.

The letter, dated August 29th, comes ten months after the Biden administration requested “the Secretary of Health and Human Services and the Attorney General to initiate the administrative process to review expeditiously how marijuana is scheduled under federal law.” While campaigning for the Presidency, Biden repeatedly promised that he would seek to reschedule marijuana.
 
Last edited:
I continue to lack the vocabulary to properly convey my utter contempt for what passes for logic and thought in our Federal government. This is a case in point. Its hard to believe that we actually pay idiots like these political appointees and Senior Exec Svc people hundreds of thousands of dollars a year.....for this kind of thinking?

Fucking imbeciles.


DEA Doubles Down on decision to fire agent who tried to replace opioids with CBD


Just when you thought things couldn’t get any weirder, the alphabet people have struck again.


The DEA has defended their decision to fire a special agent who tested positive for cannabis after using CBD oil to replace opiates, drugs which if I’m not mistaken his employer spends a great deal of time, money and press releases to help people stay away from.

The Drug Enforcement Administration recently defended their decision to fire an “outstanding” special agent fired earlier this year for using CBD oil to replace his pain medication, a decision which caused him to test positive for cannabis on a drug test.

According to court documents, Special Agent Anthony Armour filed a wrongful termination lawsuit in May of this year against the DEA. A response brief was filed recently in which the DEA fully defends their decision to terminate Agent Armour, calling his actions “reckless” and “incompatible with the agency’s sole mission to enforce our Nation’s drug laws.”

Armour served as a DEA agent for 15 years before he was subjected to a random drug screening which came back positive for THC. Armour reportedly came forward voluntarily with samples of the CBD products he was using for lab analysis, two out of three of which came back under the .3% THC limit set by the Controlled Substances Act, and the third came in at .35% which is within the acceptable margin for error.

Armour also stated in his lawsuit that he was using the CBD products to treat pain from injuries sustained playing football and during his career in law enforcement. Needless to say, as a member of the DEA, Armour was fully aware of the dangers of opioids and alleged that he was using the CBD as an alternative to his pain medication, pursuant to the 2018 Farm Bill which legalized commercial hemp products (and a whole slough of other weird shit).

“For Armour and many others in this country, this change meant new opportunities—particularly as to CBD, a non-THC cannabinoid in the cannabis plant,” the lawsuit said. “Armour hoped CBD oils could play a role in his pain management. That he did is unsurprising. From Martha Stewart to Wrigley Field, CBD has become embedded in American culture.”

Despite Armour’s rationale and despite the lawsuit he filed, the DEA doubled down on their decision in their court response brief filed August 30.

“Mr. Armour was an outstanding DEA agent when he took a chance in 2019. He believed it was unlikely that CBD products would cause him to test positive for marijuana, but he knew it was possible, and he bought those unregulated products on the internet and consumed them anyway,” the brief said. “Mr. Armour argues that he ‘displayed negligence or poor decision-making,’ and DEA properly held him accountable for his poor decisions when they resulted in a verified positive drug test. DEA lost trust in Mr. Armour and properly removed him.”

The response brief was filed just days prior to the Department of Health and Human Services official recommendation to move cannabis to Schedule 3, putting the ball into the DEA’s court to decide whether or not to honor the recommendation of the DHHS. It is not immediately clear if rescheduling cannabis would allow federal employees like Agent Armour to use cannabis products.

The filing went on to say: “This was an unfortunate ending to a lengthy and productive career in Federal law enforcement. But DEA is charged with enforcing our Nation’s drug laws, and Federal employees are responsible for what they put in their bodies. There is a clear and genuine nexus between a removal for illegal drug use and the efficiency of the service at a drug enforcement agency.”

The DEA has clarified since terminating Armour in 2020 that agents are under no circumstances to use any CBD products for exactly this reason. All hemp contains at least trace amounts of THC (hemp and cannabis are the same plant after all) and thus, it’s far too easy to accidentally or mistakenly test positive for THC while using such products. They have also clarified that synthetic cannabinoids and some of the hemp-derived cannabinoids are not legal products in their purview. Their tireless fight against opioid abuse also carries on, if not in a somewhat contradictory fashion.

“One wonders then, why they are in federal court defending the termination of a special agent who was taking these dangerous drugs off the street for doing nothing other than, for his pain, ingesting a product advertised as CBD oil that, unbeknownst to him, would test right at the border between hemp and marijuana—precisely because he didn’t want to use opiates,” an attorney for Armour said to Marijuana Moment on Friday.
 
Fuck these assholes and I guarantee that way more that a few of our Congressional representatives drink alcohol like fish and pop narcs, Valium, Xanax, etc and whatever the anti-depressant de jour is. I fucking hate politicians....all of them. Not sure I would ever allow one to be unattended on my property as they are all lying, self-serving scumbags IMO.

Weed wins galvanize Capitol Hill’s anti-cannabis club


Legalization skeptics have scored some recent victories thwarting marijuana bills.


Fighting weed legalization on Capitol Hill can feel like a lonely struggle these days.


Marijuana is just as popular as ever. More than half of Americans now live in states where adults can legally possess the drug, and just over two-thirds support federal legalization. In Congress, more and more lawmakers — on both sides of the aisle — express some form of support for legal cannabis in the states.


Yet a small but vocal, ad-hoc coalition of lawmakers — almost all Republicans — is keeping the anti-weed fight alive in Washington. And they’re not exactly losing.


The lawmakers, while still disorganized, scored several notable victories in recent months, thwarting progress on key cannabis bills and leaving die-hard supporters of federal legalization conceding they had been briefly outmaneuvered.


“We have entered the ‘fight you’ stage,” said Justin Strekal, founder of a pro-legalization PAC and former political director at the National Organization for the Reform of Marijuana Laws. The losses to the conservative lawmakers, Strekal said, offered a reminder that things “can go very wrong at the very end.”


A late 2022 deal between Majority Leader Chuck Schumer and Sen. Steve Daines (R-Mont.) to move a trio of cannabis bills through the Senate seemed to galvanize the long-existing opposition.


Then, in April, many were surprised when a bill that would instruct the Department of Veterans Affairs to research the use of marijuana on ailments like PTSD — which passed unanimously out of committee — was derailed after facing conservative pressure. The methodology and necessity of the research proposed in the bill was criticized heavily by Sen. James Lankford (R-Okla.) during a GOP caucus meeting.


More recently, 14 lawmakers led by Lankford and Rep. Pete Sessions (R-Texas) signed a letter to the DEA asking the agency to reject the Department of Health and Human Services’ recommendation to loosen federal marijuana restrictions. Sens. Daines and Cynthia Lummis (R-Wyo.) introduced a similar bill soon after to require congressional approval of any decision to change marijuana’s federal categorization.


“I just look at the cultural effects and the legal outcomes of this,” Lankford said in an interview, “and think, why would we as a nation say, ‘this is going so well we should do more of it’?”


Despite the setbacks, there is still significant momentum behind cannabis legislation on the Hill. A bill to expand access to banking services for the cannabis industry progressed out of the Senate Banking Committee last month with bipartisan support. That same bill passed the House twice in recent years with more than 100 Republicans voting in favor. And earlier this year, President Joe Biden signed the first-ever standalone cannabis bill, which will expand medical marijuana research.


The anti-weed caucus, despite growing more vocal, lacks the cohesive strategy their counterparts in the pro-cannabis caucus have employed for years.


“It’s not coordinated,” said Lummis, who led the DEA bill but said she was not looped in with signers of the DEA letter.


Some long-time weed foes — Reps. Sessions and Andy Biggs (R-Ariz.) and Sen. Tom Cotton (R-Ark.) — have been involved in recent efforts to stymie cannabis policy changes.


Lankford, meanwhile, has long been outspoken on cannabis, and has emerged as a leader among the anti-weed lawmakers in the last 12 months. He successfully whipped against the veterans research bill and organized the letter asking the DEA to reject HHS’ rescheduling recommendation.


Lankford’s motivation comes from a very similar place to lawmakers who have advocated for veterans’ access to cannabis or for medical marijuana use: anecdotes from his constituents. In his more than 20 years working as a youth pastor, he said he cannot remember a time when using marijuana made things better for a kid or their family — and countless times that it made a situation worse. Lankford also referenced the explosion of illicit marijuana cultivation in Oklahoma following medical marijuana legalization in 2018.


“We’ve opened up marijuana without any kind of regulation of any significance for what the product is and how it’s delivered,” he said. “And we’ve accelerated through that door.”


Lankford and nearly a dozen other members of the House and Senate said in interviews that none of the recent steps taken to fight new cannabis laws has translated into a concerted effort to organize against legalization.


“I can’t tell you what others are doing, but I can tell you that I’m opposed,” Sen. Ted Budd (R-N.C.) — who signed the DEA letter — told POLITICO.


Rep. Buddy Carter (R-Ga.), a pharmacist who is in favor of marijuana research and medicinal use, also signed the rescheduling letter — but didn’t know who circulated it.


“I am in favor of the medicinal use of the basic ingredients — but I’m not in favor of the recreational use of marijuana,” Carter said. “Most people know that and that’s probably why they circulated it to me.”


Contrast that with the organized efforts of pro-cannabis advocates: Legislative staff and a wide range of stakeholders regularly meet to game out strategy. The SAFE Banking Act in particular has the might and money of the American Bankers Association and Scotts Miracle-Gro behind it, and legalization is supported by other influential K street groups like the Wine and Spirits Wholesalers of America.


The Congressional Cannabis Caucus has existed for multiple congresses and is chaired by two Democrats and two Republicans. Rep. Earl Blumenauer (D-Ore.), one of the caucus co-chairs and Congress’ unofficial cannabis policy czar, created a blueprint to legalization that advocates and lobbyists still reference when discussing the path forward.


Most of the cohesion in the anti-weed movement — said Luke Niforatos, executive vice president of Smart Approaches to Marijuana, the leading anti-legalization advocacy group — comes from advocates and lobbying groups, not lawmakers’ offices themselves. He said SAM worked with Lankford on the letter and regularly connects offices they know are opposed to marijuana legislation.


“While I don’t think there’s like some master plan document, there’s a lot of very sophisticated communication and coordination in terms of the end goal,” said Niforatos.


The conservative advocacy groups Eagle Forum and Family Research Council are also working on this issue on Capitol Hill, he said. Family Research Council confirmed it is working against federal cannabis legislation, including the SAFE Banking Act. But neither group listed cannabis in their recent lobbying disclosures, and Eagle Forum did not respond to requests for comment.


“By definition, when you’re playing defense, you’re waiting to see what the offense is going to do,” Niforatos said. “So you’re a little bit behind the people that are trying to pass something, pretty much always.”


Further complicating collective action are the often-overlapping shades of support and opposition for cannabis policy on Capitol Hill. The line of delineation between the two sides weaves and curves from bill to bill.


Lawmakers like Carter strongly oppose legalization but are open to medical marijuana in certain situations. Conversely, strong supporters of the cannabis banking bill — including Lummis, Daines and Sen. Kevin Cramer (R-N.D.) — are opposed to federal decriminalization. And Rep. Dave Joyce (R-Ohio) supports decriminalization but opposed a House bill to do so that did not include a regulatory and taxation framework for the new industry.


“This highlights the growing fracture within the Republican caucus,” Strekal said, “on those who want to double down on criminalization versus those who want to accept the legitimacy of states legalizing marijuana.”
 
"merely possessing a medical cannabis card as a patient does render a person ineligible" (sic...from owning a firearm). This is utter bullshit. Its like saying that having a driver's license is proof that you own a car and actually do drive...one does not NECESSARILY follow the other.

And fuck the DOJ, FBI, DEA, and ATF...fucking wankers one and all. Their position is untenable horseshit and multiple Fed District and Appeals courts have said so...but the drug warriors keep on fighting. This needs to get to SCOTUS asap to finally be settled.

Medical Marijuana Growers And Caregivers Can Own Guns, But Patients Can’t, FBI Says In Little-Noticed Memo


Being a state-registered medical marijuana caregiver or grower doesn’t automatically disqualify a person from owning a firearm, the FBI says. But merely possessing a medical cannabis card as a patient does render a person ineligible.

Amid the growing tension between federal gun policies and the ever-expanding state marijuana legalization movement, a little-noticed FBI memo from 2019 offers a lens into the byzantine legal interpretations surrounding cannabis and firearms—an issue that’s recently been raised in multiple federal court cases.

The government has several different ways it assesses firearm eligibility in the context of cannabis, according to the memo from FBI’s Criminal Justice Information Services (CJIS) Division, which was briefly noted in a report from The New York Times last week. In some cases, that involves affirmatively restricting gun rights based on activities or documentation that doesn’t necessarily mean a person is an active marijuana consumer.

At their core, the federal rules say that being an “unlawful user” of a controlled substance, including marijuana, means a person cannot buy or possess a gun. Would-be gun purchasers are required to disclose such use as part of a Bureau of Alcohol, Tobacco, Firearms and Explosives (ATF) form before making a purchase, and lying on that form is a felony offense.

The statute behind that prohibition has been challenged in a number of federal courts over the past couple of years, with more than one judicial body determining that the restriction is unconstitutional. The Department of Justice (DOJ) has steadfastly defended the ban, however, contending that medical marijuana patients and everyday consumers pose unique dangers to society that justify withholding Second Amendment rights.

But the federal government’s interpretation of the policy is apparently more nuanced, as evidenced by the memo from CJIS’s National Instant Criminal Background Check System Section that’s gone largely unscrutinized since being published more than four years ago.

A person’s firearm eligibility is partly determined by whether their use of a controlled substance is deemed “current.” FBI says that’s “not limited to the use of drugs on a particular day, or within a matter of days or weeks before, but rather that the unlawful use has occurred recently enough to indicate the individual is actively engaged in such conduct.”

“ATF has determined that the present time is represented by the time frame of within the past 12 months,” the memo says.

But making the determination also involves an “inference of current use or possession” that may be “drawn from evidence of recent use or possession” or a “pattern of use or possession that reasonably covers the present time.”

What constitutes such “evidence” isn’t quite so simple, however.

For example, if a person admits to using marijuana—or if they are “in possession of a medical marijuana user card”—that is “enough to establish an inference of current use for the federal drug prohibition,” the document says, even without additional evidence of actual current use. “The information may be obtained by an individual admitting they have a medical marijuana user card or by presenting a copy of the medical marijuana user card within the past year.”

“The following scenarios will be used to determine the disqualification period in regard to possession of a medical marijuana user card:

1. One year from the date of the medical marijuana user card’s expiration date; or
2. One year from the date of ‘admission’ of possession of the medical marijuana user card, if no expiration date is available; or
3. One year from the date the medical marijuana user card is relinquished.”
Notably, the memo does carve out certain exceptions to its cannabis rules for gun ownership, clarifying that possession of marijuana is not disqualifying if the person is identified as a medical cannabis “caregiver, grower, provider, etc.”

“Use of the marijuana (or other controlled substance) must be established for the prohibition to exist,” FBI says. “Similarly, an individual may possess a medical marijuana handler’s card as a caregiver, grower, or provider for another party, but would not be disqualified, unless use was established.”

Other rules detailed in the memo apply broadly to any controlled substance but stand out for their administrative specificity.

For instance, when a person is convicted of possession or use of an illicit drug, FBI counts that as evidence of present use within the last year—regardless of the length of time since the arrest itself. If a person is arrested but their conviction is deferred (e.g. through a pretrial diversion program), that judgment cannot be used as evidence of current use. Instead, the memo says, that information must be gleaned from the arrest report.

When it comes to arrests for drug paraphernalia, that on its own isn’t automatically disqualifying for firearm ownership. However, such an arrest in the past year “can also be researched to determine if the incident report shows the individual admitted to the use or possession of a controlled substance at the time of the paraphernalia arrest.”

Drug tests can also be used as evidence to restrict gun rights under certain circumstances. While the memo says an individual officer’s assessment, or a drug-sniffing dog detecting a controlled substances, cannot be used as the evidentiary basis, an incident report about a “baggie containing a ‘green leafy material’ from the subject’s shirt pocket” that tests positive for cannabis can be considered proof of current drug use.

It’s not clear if any of the rules detailed in the 2019 memo have been updated or revised since their issuance. Marijuana Moment reached out to the FBI for clarification, but a representative was not immediately available.

In the years since the document was issued, numerous additional states have adopted laws legalizing cannabis for medical or recreational use. And the widening gap separating state and federal marijuana laws has prompted legal challenges to the underlying ban.

Last month, for example, the Justice Department told the U.S. Court of Appeals for the Third Circuit that historical precedent “comfortably” supports the restriction. Cannabis consumers with guns pose a unique danger to society, the Biden administration claimed, in part because they’re “unlikely” to store their weapon properly.
In a brief submitted in that case, attorneys for the Justice Department argued the firearm ban for marijuana consumers is further justified based on historical analogues to restrictions on the mentally ill and habitually drunk that were imposed during the time of the Second Amendment’s ratification in 1791.
The federal government has repeatedly claimed that those analogues provide clear support for limiting gun rights for cannabis users. But several federal courts have separately deemed the marijuana-related ban unconstitutional, leading DOJ to appeal in several ongoing cases.

The Justice Department asserted similar points during oral arguments in a separate but related case before the U.S. Court of Appeals for the Eleventh Circuit in October. That case focuses on the Second Amendment rights of medical cannabis patients in Florida.

Attorneys in both cases have also touched on a U.S. Court of Appeals for the Fifth Circuit ruling from August, Daniels v. United States, that found the ban preventing people who use marijuana from possessing firearms is unconstitutional, even if they consume cannabis for non-medical reasons.

DOJ had already advised the Eleventh Circuit court that it felt the ruling was “incorrectly decided,” and the department’s attorney reiterated that it’s the government’s belief that “there are some reasons to be uncertain about the foundations” of the appeals court decision.

The U.S. District Court for the Western District of Oklahoma also ruled in February that the ban prohibiting people who use marijuana from possessing firearms is unconstitutional, with the judge stating that the federal government’s justification for upholding the law is “concerning.”

In U.S. District Court for the Western District of Texas, a judge ruled in April that banning people who use marijuana from possessing firearms is unconstitutional—and it said the same legal principle also applies to the sale and transfer of guns.

In August, meanwhile, ATF sent a letter to Arkansas officials saying that the state’s recently enacted law permitting medical cannabis patients to obtain concealed carry gun licenses “creates an unacceptable risk,” and could jeopardize the state’s federally approved alternative firearm licensing policy.

Shortly after Minnesota’s governor signed a legalization bill into law in May, the agency issued a reminder emphasizing that people who use cannabis are barred from possessing and purchases guns and ammunition “until” federal prohibition ends.

In 2020, ATF issued an advisory specifically targeting Michigan that requires gun sellers to conduct federal background checks on all unlicensed gun buyers because it said the state’s cannabis laws had enabled “habitual marijuana users” and other disqualified individuals to obtain firearms illegally.

Meanwhile, attorneys for President Joe Biden’s son Hunter—who has been indicted on a charge of buying a gun in 2018 at a time when he’s disclosed that he was an active user of crack cocaine—have previously cited the court ruling on the unconstitutionality of the federal ban, arguing that it applies to their client’s case as well.
Republican congressional lawmakers have filed two bills so far this session that focus on gun and marijuana policy.

Rep. Brian Mast (R-FL), co-chair of the Congressional Cannabis Caucus, filed legislation in May to protect the Second Amendment rights of people who use marijuana in legal states, allowing them to purchase and possess firearms that they’re currently prohibited from having under federal law.

Senate Majority Leader Chuck Schumer (D-NY) has committed to attaching that legislation to a bipartisan marijuana banking bill that advanced out of committee last month and is pending floor action.

Meanwhile, Mast is also cosponsoring a separate bill from Rep. Alex Mooney (R-WV) this session that would more narrowly allow medical cannabis patients to purchase and possess firearms.

One place where the matter is particularly relevant is Jersey City, New Jersey, where Mayor Steven M. Fulop (D) is suing over a state policy that allows police officers to use marijuana while off duty.

That challenge, however, has sparked pushback from two police officers, who’ve since sued Jersey City over what they say is a politically motivated move by Fulop in service of a future gubernatorial campaign.
 
Fuck these assholes and I guarantee that way more that a few of our Congressional representatives drink alcohol like fish and pop narcs, Valium, Xanax, etc and whatever the anti-depressant de jour is. I fucking hate politicians....all of them. Not sure I would ever allow one to be unattended on my property as they are all lying, self-serving scumbags IMO.

Okay, but c'mon B23, don't hold back, please share with us how you really feel!! :rofl::rofl::rofl:

SERIOUSLY, COULD NOT AGREE WITH YOU MORE!
 
I put this article in this tread due to this fuckwittery: "the DEA is understood to have launched its review, but has insisted that it retains the “final authority to schedule, reschedule, or deschedule a drug under the Controlled Substances Act, after considering the relevant statutory and regulatory criteria and HHS’s scientific and medical evaluation”.

Fuck the DEA...the only authority they have is via Congressional legislation and that conveyed to them from the White House on down....all venal politicians who won't do a thing to rein in this asshole un-elected drug warriors.
1704400566687.png

US Cannabis Stocks Spike as DEA Confirms Cannabis Reclassification Review


US DEA Confirms Cannabis Rescheduling Review Amid Power Struggle.


The US Drug Enforcement Administration (DEA) has confirmed that it is conducting a review into the reclassification of cannabis, but has asserted its ‘final authority’ over the decision.


In a letter sent to congressional Cannabis Caucus co-chair Rep. Earl Blumenauer, seen by Punchbowl News, the DEA said it was ‘now conducting its review’ into the potential rescheduling of cannabis.


The latest development is part of a scheduling review process launched by President Biden in October 2022, which saw the Department of Health and Human Services (HHS) recommend that the DEA change cannabis from a Schedule I to a Schedule III substance, potentially giving the US industry a significant federal boost.


Following the recommendation, the DEA is understood to have launched its review, but has insisted that it retains the “final authority to schedule, reschedule, or deschedule a drug under the Controlled Substances Act, after considering the relevant statutory and regulatory criteria and HHS’s scientific and medical evaluation”.


While previous precedent suggests the DEA will follow the HHS’s advice, the letter, sent last month, has been seen as a power play among lawmakers, emphasised by the DEA’s refusal to provide any sort of timeline or insight into its position in the letter.
 
“The plague is the black market of marijuana and certainly cartel activity, and a number of victims are out there,”

For those without any insight into history, alcohol prohibition was Miracle Grow for organized crime and mob activities. As it is with cannabis.

And as our shithead Federal politicians and their unelected bureaucracy dither around, this crap continues to happen.


Marijuana dispute led to desert massacre; 5 suspects arrested


Five men have been arrested in a gruesome multiple slaying in a remote part of the Mojave Desert in San Bernardino County.​


Six men were fatally shot — and four of them were also severely burned — in Tuesday’s incident, authorities say. Their bodies were left scattered amid the desert landscape.


The motive behind the violence was a dispute over marijuana, investigators say. Possible connections to cartel activity are being explored.


The San Bernardino County Sheriff’s Department served search warrants in Apple Valley, Adelanto and the Los Angeles County area of Piñon Hills, identifying five suspects in the slayings, which took place in the community of El Mirage, authorities said Monday.


Investigators arrested Toniel Baez-Duarte, 34; Mateo Baez-Duarte, 24; Jose Nicolas Hernandez-Sarabia, 33; Jose Gregorio Hernandez-Sarabia, 34; and Jose Manuel Burgos Parra. 26.


“The moment we started this investigation, we started to receive strong leads,” San Bernardino County Sheriff Shannon Dicus said at a news conference Monday evening.


On Tuesday at 8:16 p.m., dispatchers received a 911 call, according to Michael Warrick, a sergeant in the specialized investigation division for the Sheriff’s Department.


The caller, speaking in Spanish, “told dispatchers he was shot,” Warrick said, “but he did not know the location he was at, and it appeared the call ended.”


Dispatchers tracked the coordinates of the phone call to an area near Lessing Avenue and Shadow Mountain Road, off U.S. Highway 395. A long north-south corridor, U.S. Highway 395 runs from Interstate 15 in Hesperia, Calif., through Carson City, Nev., to the Canadian border.


With the assistance of the California Highway Patrol air operations unit, officers discovered a crime scene with multiple shooting victims and two vehicles, a Dodge Caravan and a Chevy Trailblazer. One of the vehicles was pocked with bullet holes. The desolate area surrounding the crime scene, about 50 miles northeast of Los Angeles, was littered with cardboard, rubber tires and broken bottles.


About an hour later, deputies from the sheriff’s Victor Valley station arrived and found four slain men with severe burns, a fifth deceased man in the Chevy Trailblazer and a sixth deceased victim a short distance away.


Four of the six have been identified. The name of one, a 45-year-old man, is being withheld pending next-of-kin notification. The last two victims have yet to be identified.


Those who have been identified are Baldemar Mondragon-Albarran, 34; Franklin Noel Bonilla, 22; and Kevin Dariel Bonilla, 25.


Warrick said Franklin Bonilla was the person who called 911 for help.


The identified victims were Latino, possibly Honduran nationals. They lived in Adelanto and Hesperia, authorities said.


Investigators said all victims sustained fatal gunshot injuries; it is believed four of the men were burned by the suspects at the location.


“We are still conducting follow-up investigation, but we are confident we have arrested all the suspects in this case,” Warrick said.


When serving warrants, detectives recovered eight firearms, which will undergo a forensic examination to determine whether any were used in the slayings, he said.


Asked whether the slayings could be cartel-related, Warrick said that he couldn’t yet comment but that there were “certain things at the scene that show a level of violence that obviously raises some interesting questions for us.”


The five suspects were arrested Sunday on suspicion of murder and are being held without bail pending a review of the case by the San Bernardino County district attorney’s office.


Illegal marijuana grows are an issue in the area, Dicus said during Monday’s news conference.


Recreational marijuana and registered marijuana grows are legal in California. Dicus, however, cited the marijuana black market as a cause of violence.


“The plague is the black market of marijuana and certainly cartel activity, and a number of victims are out there,” he said.
 
Fuck Harris...he's been a drug cold warrior from jump street and is single-handedly responsible for blocking the District of Columbia from opening a regulated cannabis market. He apparently thinks its much better to do drug deals on Benning Road at 1 am on a Saturday night. sigh

But, he represents the eastern shore which is the only Republican majority area in an state that is vastly predominantly blue and dominated by its two urban centers of Baltimore and the DC suburbs. He ain't going away.....sadly.


FDA Reached ‘Flawed’ And ‘Misguided Conclusion’ To Reschedule Marijuana, GOP Congressman Tells DEA Administrator


A Republican congressman who has long opposed marijuana reform is telling the Drug Enforcement Administration (DEA) that the Food and Drug Administration (FDA) came to a “misguided conclusion” to recommend rescheduling cannabis— challenging the health agency’s scientific standards and imploring DEA to dismiss them as it prepares to make a final determination.

In a letter sent to DEA Administrator Anne Milgram on Wednesday, Rep. Andy Harris (R-MD) also said the agency should “abide by our nation’s international treaty obligations” that he says prohibit the U.S. from moving cannabis to Schedule III of the Controlled Substances Act (CSA), as the U.S. Department of Health and Human Services (HHS) has recommended.

“The treaty established widely agreed upon methods of drug control that are still used today,” Harris said, adding that any reclassification that puts marijuana outside of Schedule I or Schedule II “would constitute a violation of the Single Convention.”
A New Poll Finds That Floridians Want Legal Marijuana

DEA has previously rejected rescheduling petitions on the basis of those decades-old treaties, but as a coalition of 12 senators recently pointed out in a separate letter to Milgram this week, the United Nations (UN) has since revised global cannabis scheduling policies, while allowing other member states such as Canada to enact complete legalization without penalization.

“In addition to considering international treaty obligations, I urge you to consider that HHS’ justification for making its recommendation to reschedule marijuana was flawed in many respects,” the congressman said in the letter.

He wrote that “FDA ignored several important factors when considering marijuana’s potential for abuse and harm to public health,” arguing that the agency “did not sufficiently examine the effect of daily marijuana use, a key indicator of addiction,” and it also “failed to consider the public health damage caused by traffic fatalities due to individuals driving under the influence of marijuana.”

“The FDA also failed to compare marijuana’s potential for abuse to many other Schedule I drugs, instead opting to hand-select drugs that appear more harmful,” he said, questioning why the agency made comparisons to the Schedule I drug heroin, but not LSD or ecstasy, for example.

“The FDA mischaracterized the data on marijuana’s harms,” Harris said in the letter, first noted
1706975499092.png
by Fox News Radio’. “The lack of rigor in the studies used by the FDA is concerning and led to a misguided conclusion.”

In addition to outlining his bifurcated argument against incremental rescheduling—which would not legalize marijuana or federally sanction state-regulated cannabis markets—Harris also demanded that DEA answer a series of related questions by February 16.

He asked Milgram to explain DEA’s current legal interpretation of international treaty obligations as it concerns marijuana, how the agency is procedurally approaching its scheduling review, whether it considers certain studies on cannabis appropriate to account for in its assessment and how it is weighing issues such as marijuana use by pregnant women and the risk of impaired driving in its review.

The congressman’s position isn’t surprising, as he’s developed a firm reputation as an opponent of marijuana reform throughout his tenure. For example, he’s sponsored and defended a longstanding appropriations rider that has blocked Washington, D.C. from implementing a system of regulated cannabis sales, despite voters approving a legalization initiative at the local ballot in 2014.

The letter to DEA also came as Harris joined two other prohibitionist lawmakers, Rep. Pete Sessions (R-TX) and Sen. Pete Ricketts (R-NE), in introducing a concurrent resolution that raises concerns about high potency THC products and calls on federal agencies to research the potential harms.

But the letter is the latest example of how lawmakers on both sides of the cannabis debate are seeking to influence DEA amid expectations about a potentially imminent scheduling decision.

For example, a separate letter sent to Milgram on Monday—led by Sens. Elizabeth Warren (D-MA) and John Fetterman (D-PA), along with Senate Majority Leader Chuck Schumer (D-NY) and other champions of marijuana reform—urged DEA to go further than rescheduling by fully removing cannabis from the CSA.

Doing so would present a “rare opportunity to shape the new cannabis industry from the ground up, designing a federal regulatory system untainted by the corporate capture that has influenced alcohol and tobacco regulations, and advancing federal cannabis reforms that acknowledge and repair the harms of cannabis criminalization,” they said.
 
Wow, how tone deaf can you be.

I did not try to screen capture and paste here the X posts that were contained in this article....for full content, follow the link in the article title, below.


DEA Slammed Over Post Commemorating Nixon’s Drug War Legacy On First Day Of Black History Month



The Drug Enforcement Administration (DEA) is facing criticism over its decision to commemorate President Richard Nixon’s drug war legacy in a social media post that coincided with the beginning of Black History Month.
DEA’s Throwback Thursday (or TBT) post on X featured a picture of Nixon receiving a “certificate of special honor” from the International Narcotic Enforcement Officers’ Association in December 1970 “in recognition of the outstanding loyalty and contribution to support narcotic law enforcement.”



Advocates blasted the homage as tone-deaf, memorializing a president whose own domestic policy advisor would later disclose that his boss promoted punitive drug laws in large part to target his political “enemies,” namely “the anti-war left and Black people.”


DEA didn’t necessarily endorse or provide commentary beyond sharing the moment in history—but the TBT post quickly incited criticism given the timing in connection to Black History Month.


It was also about six months after the photo of Nixon was taken that he’d infamously declare a war on drugs, fueling a mass incarceration movement that would have racially disparate impacts lasting generations into the modern day.


As the Drug Policy Alliance (DPA) pointed out, 1970 also marked the year that Nixon signed the Controlled Substances Act (CSA), codifying broad drug criminalization in a way that has long empowered DEA and is actively being reviewed by the agency as it weighs a marijuana rescheduling recommendation from the U.S. Department of Health and Human Services (HHS).


“This is the agency that we are supposed to trust to objectively decide cannabis final schedule?” Kaliko Castille, who recently ended his tenure as president of the Minority Cannabis Business Association (MCBA), said. “Posting drug war propaganda to kick off the first day of Black History Month?”

Cat Packer, director of drug markets and legal regulation at DPA, shared the sentiment.



“On the first day of Black History Month 2024 the Biden Administration’s DEA is celebrating President Nixon—this is the same agency responsible for marijuana scheduling,” she said.


Here’s how others reacted to DEA’s Nixon post:


The unpopularity of the drug war and DEA’s role in that crusade hasn’t stopped the agency from celebrating its history.



Last year, for example, it touted its 50-year anniversary, marking a half century of enforcing criminalization laws that have failed to fulfill the mission to eradicate drugs at the same time that nearly half of the country has legalized marijuana and psychedelics reform is also booming.


DEA’s own museum is rife with subtle acknowledgements that the agency has failed to win the drug war. In 2022, the museum even publicly recognized the fact that racially discriminatory drug laws are partly responsible for the agency’s own founding.



In any case, the agency is now actively completing a review into cannabis scheduling that could either depart from, or reinforce, its reputation with the public that’s invited criticism. While HHS has advised DEA to move marijuana from Schedule I to Schedule III of the CSA, the law enforcement agency has emphasized that it reserves “final authority” in the matter, so it remains to be seen.
 

Sponsored by

VGoodiez 420EDC
Back
Top